Intrinsic Value of S&P & Nasdaq Contact Us

SurgePays, Inc. SURG NASDAQ

NASDAQ Capital Marke • Technology • Software - Application • US • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+1717.9%

SurgePays, Inc. (SURG) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 4 Buy, 2 Hold.

The consensus price target is $10.00, representing an upside of 1717.9% from the current price $0.55.

Analysts estimate Earnings Per Share (EPS) of $-1.60 and revenue of $0.06B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.39 vs est $-1.60 (missed -49.8%). Analyst accuracy: 67%.

SURG Stock — 12-Month Price Forecast

$10.00
▲ +1,717.85% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for SurgePays, Inc., the price target is $10.00.
The average price target represents a +1,717.85% change from the last price of $0.55.

SURG Analyst Ratings

Buy
6
Ratings
4 Buy
2 Hold
Based on 6 analysts giving stock ratings to SurgePays, Inc. in the past 3 months
Rating breakdown
Buy
4 67%
Hold
2 33%
67%
Buy
4 analysts
33%
Hold
2 analysts
0%
Sell
0 analysts

EPS Estimates — SURG

67%
Analyst Accuracy
Fair
1 year compared
Actual vs Estimate
2024 Actual –$2.39 vs Est –$1.60 ▼ 33.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — SURG

98%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.061B vs Est $0.060B ▲ 2.2% off
Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message